Koninklijke Philips (NYSE:PHG) Announces Quarterly Earnings Results

Koninklijke Philips (NYSE:PHG - Get Free Report) issued its quarterly earnings data on Wednesday. The technology company reported $0.54 EPS for the quarter, missing the consensus estimate of $0.55 by ($0.01), Zacks reports. The company had revenue of $5.38 billion during the quarter, compared to analysts' expectations of $5.10 billion. Koninklijke Philips had a positive return on equity of 10.85% and a negative net margin of 3.88%.

Koninklijke Philips Stock Performance

Shares of PHG stock traded up $0.50 during trading on Friday, hitting $25.53. The company's stock had a trading volume of 2,295,393 shares, compared to its average volume of 710,086. The company has a market cap of $24.00 billion, a PE ratio of -30.40, a P/E/G ratio of 0.82 and a beta of 0.77. The company has a current ratio of 1.23, a quick ratio of 0.74 and a debt-to-equity ratio of 0.59. The business has a fifty day moving average of $26.25 and a 200-day moving average of $28.14. Koninklijke Philips has a 52 week low of $19.75 and a 52 week high of $32.91.

Analyst Ratings Changes

Several analysts have recently commented on PHG shares. StockNews.com raised Koninklijke Philips from a "hold" rating to a "buy" rating in a research note on Thursday. Jefferies Financial Group raised Koninklijke Philips from an "underperform" rating to a "hold" rating in a research note on Tuesday, October 29th. Finally, UBS Group raised Koninklijke Philips from a "neutral" rating to a "buy" rating in a research note on Thursday. Three equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat, Koninklijke Philips presently has a consensus rating of "Moderate Buy".

About Koninklijke Philips

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.